Table I.
ESC treatment | Phospho-ERK1/2 (nuclear pixels % relative to control) |
---|---|
Control | 100 ± 5% |
IL-1β | 211 ± 7%* |
PD98059 | 84 ± 4%* |
IL-1β + PD98059 | 111 ± 4%** |
* P < 0.01 vs control.
** P < 0.05 vs PD98059
ESC treatment | Phospho-ERK1/2 (nuclear pixels % relative to control) |
---|---|
Control | 100 ± 5% |
IL-1β | 211 ± 7%* |
PD98059 | 84 ± 4%* |
IL-1β + PD98059 | 111 ± 4%** |
* P < 0.01 vs control.
** P < 0.05 vs PD98059